Screening of Fungi for Antimycobacterial Activity Using a Medium-Throughput Bioluminescence-Based Assay
- Author: mycolabadmin
- 2021-09-06
- View Source
Summary
This research explored using fungi to find new antibiotics that could treat dangerous bacterial infections like tuberculosis. The scientists developed a new method to test fungi for their ability to kill harmful bacteria by using bacteria that glow in the dark – when the fungi kill the bacteria, the glow dims or disappears. This helps quickly identify which fungi might produce useful new medicines.
Impacts on everyday life:
– Could lead to new antibiotics to treat drug-resistant infections
– Demonstrates the importance of preserving fungal biodiversity as a source of new medicines
– Provides a faster way to screen natural compounds for antibiotic properties
– Shows the value of indigenous ecosystems like those in New Zealand for drug discovery
– Highlights how basic science tools like bioluminescence can accelerate medical research
Background
There is an urgent need for new antibiotics to kill Mycobacteria, which are acid-fast bacilli capable of causing multiple deadly diseases including tuberculosis (TB) and non-tuberculous Mycobacteria (NTM) infections. Treatment of mycobacterial infections can take months to years and require multiple antibiotics due to their slow growth and hydrophobic, lipid-rich outer membrane.
Objective
To develop and implement a medium-throughput bioluminescence-based pipeline to screen fungi for activity against Mycobacteria using the NTM species Mycobacterium abscessus and Mycobacterium marinum as test organisms.
Results
Almost all tested fungal isolates produced considerable anti-mycobacterial activity. More isolates (94%) were active against M. marinum compared to M. abscessus (77%). Growth media significantly impacted antibacterial activity. Chemical analysis revealed much activity was due to linoleic acid production, but several isolates retained activity in non-linoleic acid containing fractions, including species of Lophodermium culmigenum, Pseudaegerita viridis, Trametes coccinea, and unknown species of Boeremia and Phanerochaetaceae.
Conclusion
The study successfully developed a screening pipeline and identified multiple fungal isolates with anti-mycobacterial activity. While some activity was attributed to known compound linoleic acid, several promising isolates showed activity through other mechanisms warranting further investigation for novel bioactive compounds.
- Published in:Frontiers in Microbiology,
- Study Type:Laboratory Research Study,
- Source: 10.3389/fmicb.2021.739995